AARTISURF vs EPIGRAL: Stock Comparison

Aarti Surfactants Limited vs Epigral Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Epigral Limited is the larger company by market capitalisation. Aarti Surfactants Limited shows faster revenue growth, while Epigral Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Aarti Surfactants Limited and Epigral Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AARTISURF is more favourable on 3 of 13 scored metrics and EPIGRAL on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
EPIGRAL is the larger company
₹5,036 Cr vs ₹323 Cr
P/E Ratio
EPIGRAL has a lower P/E
15.04x vs 26.27x
P/B Ratio
AARTISURF has a lower P/B
1.32x vs 2.25x
EPS
EPIGRAL has higher earnings per share
₹75.27 vs ₹14.57
Dividend Yield
EPIGRAL has a higher dividend yield
0.43% vs 0.25%
Revenue Growth (TTM YoY)
AARTISURF has faster revenue growth
26.8% vs 17.3%
EPS Growth (TTM YoY)
EPIGRAL has faster EPS growth
-6.8% vs -57%
Qtr Sales Growth
AARTISURF has stronger quarterly sales growth
26.8% vs 17.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAARTISURFEPIGRAL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricAARTISURFEPIGRAL
Live Price₹381.6₹1,162.7
Day Change-1.09%0.93%
Volume6,2473.02 L
52-Week High₹516.6₹2,114
52-Week Low₹316₹807
Distance from 52W High-26.13%-45%

Valuation

MetricAARTISURFEPIGRAL
Market Cap₹323 Cr₹5,036 Cr
P/E Ratio26.27x15.04x
P/B Ratio1.32x2.25x
EPS₹14.57₹75.27
Book Value₹289.66₹514.92
Dividend Yield0.25%0.43%

Growth

MetricAARTISURFEPIGRAL
Revenue Growth (TTM YoY)26.8%17.3%
EPS Growth (TTM YoY)-57%-6.8%
Qtr Sales Growth26.8%17.3%
Qtr Profit Growth-56.9%-6.84%

Profitability & Leverage

MetricAARTISURFEPIGRAL
ROE5.17%16%
ROCE8.53%15.5%
Net Margin1.44%13.14%
Operating Margin5.46%22.4%
Debt to Equity0.43x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAARTISURFEPIGRAL
Promoter Holding49.63% 0.03 pp68.83%
FII Holding0.08% 0.06 pp1.03% 0.51 pp
DII Holding0%5.56% 0.66 pp
Public Holding50.07% 0.09 pp24.55% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Aarti Surfactants Limited and Epigral Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.